HCS Pharma marked its presence at ELRIG UK Drug Discovery 2023, demonstrating its commitment to innovation in drug discovery. At this major pharmaceutical industry event, with the presence of Veronique De Conto (Project Leader in in vitro Pharmacology) and Paul Couvreur (Key Account Manager), HCS Pharma highlighted its poster about High Content Screening and 3D cell culture. The company also had the opportunity to meet key industry players and exchange ideas. HCS Pharma’s participation in ELRIG UK Drug Discovery 2023 reinforced its position as a key player in the pharmaceutical research sector, demonstrating its commitment to making a significant contribution to the advancement of medical therapies and the discovery of new medicines to improve the health and well-being of all.

We are also delighted to welcome our partner Molecular Devices to their stand. It was a pleasure to talk to Andy Bashford and James Wilson.

Categories: NewsOur news


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.